© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Giving A Personal Touch to Clinical Trials
Posted 1st March 2018

Giving A Personal Touch to Clinical Trials

GlobalCare Clinical Trials brings over 100 years of experience in the clinical trials and home healthcare industries supporting over 400 studies in over 50 countries by effectively delivering high quality and convenient clinical trial services in the home or alternate-site setting.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Giving A Personal Touch to Clinical Trials
Image

Giving A Personal Touch to Clinical Trials

GlobalCare Clinical Trials brings over 100 years of experience in the clinical trials and home healthcare industries supporting over 400 studies in over 50 countries by effectively delivering high quality and convenient clinical trial services in the home or alternate-site setting. We profile the firm and explore how CEO Gail Adinamis, winner of CEO of the Year – Illinois in our prestigious 2017 CEO of the Year Awards, has helped drive the firm to the success it enjoys today.

Since its inception in 2010, GlobalCare has created a strong reputation for itself, and today it is a leading company specializing in the provision of in-home clinical trial visits via a global network of mobile clinicians to facilitate a variety of therapeutic areas in all phases of clinical trials. The company maintains a global clinical network of ambulant clinicians and Country Coordinators and operates offices in North America and Europe. GlobalCare supports all phases of clinical trials in a variety of therapeutic areas, genomics and personalized medicine in all age groups.

To ensure excellence for clients, GlobalCare’s network of high skilled nurses and physicians provide blood draws, pharyngeal swabs, ECGs, study drug administration, clinical assessments, questionnaires, training and data collection. Additionally, the firm’s traveling clinicians provide patients with a convenient way to participate in trials regardless of study duration, frequency of visits, their disease state or distance to the study site. Its patient-centric approach helps to accelerate patient recruitment and improve study patient compliance and retention.

Gail Adinamis is CEO of GlobalCare, drawing on her expertise as a seasoned executive and successful entrepreneur with three decades of comprehensive phase I-IV clinical trials experience including over 12 years of global clinical trials management at Abbott Laboratories and Astellas Pharma US. She also established the clinical trials divisions for three national homecare companies and served as president of those wholly-owned subsidiaries. Most recently Gail founded and served as president and CEO of Clinical Resource Network, LLC.

Alongside this, Gail is also a member of the Women Presidents’ Organization, DIA, ACRP, and the Healthcare Businesswomen’s Association and has been an invited speaker at several industry conferences.

In her role as CEO, Gail provides vision, leadership, strategic planning and oversight for GlobalCare. She founded the business model for centrally managed in-home and alternate site services for clinical trials in 1992, and since then has remained dedicated to supporting the firm and driving it to even greater success.

Overall, GlobalCare’s mission is to provide a patientcentric approach to clinical trials to speed the delivery of new products to the marketplace, and moving forward this will remain its ongoing focus as it looks towards a bright and exciting future.

Company: GlobalCare Clinical Trials

Contact: Gail Adinamis

Address: 2201 Waukegan Road, Suite 300, Bannockburn, Illinois, 60015, USA

Phone: 001 847 282 3270

Website: http://globalcarect.com/

 

Categories: Innovation


You Might Also Like
Read Full PostRead - Eye Icon
5 Best Practices Of Project Development
Strategy
22/02/20235 Best Practices Of Project Development

Would you plan out every minute of your day if it would improve your life experiences? Some people would agree to this course of action if given a chance, especially since planning has been proven to contribute to the success of any endeavour. The same princip

Read Full PostRead - Eye Icon
Machine Learning Will Make Almost 70% of Total AI Market Value in 2024
Innovation
19/03/2024Machine Learning Will Make Almost 70% of Total AI Market Value in 2024

The surging demand for AI-driven solutions across industries continues fuelling machine learning market growth, helping it reach a new record valuation and further increase its market share in the artificial intelligence landscape.

Read Full PostRead - Eye Icon
Anywhere365® Awarded Most Innovative Cloud-Based Contact Centre Platform 2021
Innovation
09/04/2021Anywhere365® Awarded Most Innovative Cloud-Based Contact Centre Platform 2021

We are happy to announce Anywhere365® as this year’s winner of the Global Excellence Award for the Most Innovative Cloud-Based Contact Centre Platform. Anywhere365® is a leading omnichannel dialogue management and cloud contact centre platform, native to M

Read Full PostRead - Eye Icon
Venture Capital Dollars Invested in Life Sciences Companies in 2014 at Highest Level Since 2007
Finance
12/03/2015Venture Capital Dollars Invested in Life Sciences Companies in 2014 at Highest Level Since 2007

Venture capitalists invested US$2.8bn in life sciences in the fourth quarter, reaching US$8.6bn in 2014, according to MoneyTree Report from PwC.

Read Full PostRead - Eye Icon
New York’s Experts in Medical Litigation
Legal
07/05/2019New York’s Experts in Medical Litigation

Since its inception, the Law Firm of Joseph M. Lichtenstein has become the go-to firm for hundreds of New Yorkers who have suffered at the hands of medical negligence. Recently, the firm found were recognised by Acquisition Intl. as 2018’s Most Outstanding M

Read Full PostRead - Eye Icon
Bridging Success in 2015
Strategy
31/01/2015Bridging Success in 2015

There is currently a huge appetite for short- and medium-term property loans across the UK, and Dragonfly Property Finance is leading the way.

Read Full PostRead - Eye Icon
Fraud Fears as FCA Investigates Over 150 Covid-19 Related Scams
Legal
09/09/2020Fraud Fears as FCA Investigates Over 150 Covid-19 Related Scams

The Financial Conduct Authority (FCA) is investigating more than 150 Coronavirus-related scams since the outbreak began, according to official figures.

Read Full PostRead - Eye Icon
Suing a Hospital for Malpractice: A Guide
News
29/08/2023Suing a Hospital for Malpractice: A Guide

A core principle of any kind of medical practice is to safeguard patient well-being. Sadly, it’s not rare to find instances of medical malpractice and negligence. When medical care falls short of accepted standards in any way, the patient has the right t

Read Full PostRead - Eye Icon
CounselCorp Advises Aurobindo (Australia) Pty Ltd During Pharma Eris Pharma’s Acquisition
M&A
06/05/2015CounselCorp Advises Aurobindo (Australia) Pty Ltd During Pharma Eris Pharma’s Acquisition

In a move to focus the growth markets, the Hyderabad-based Aurobindo Pharma has sold off its step-down subsidiary in Australia, Aurobindo Pharma (Australia) Pty Ltd, to Eris Pharma Australia Pty Ltd.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow